Myriad Genetics, Inc. (NASDAQ:MYGN) Q4 2022 Earnings Call Transcript

Operator: Greetings, and welcome to the Myriad Genetics Fourth Quarter 2022 Financial Earnings Conference Call. During the presentation, all participants will be in a listen-only mode.

Related Keywords

California ,United States ,Mark Verratti ,Matt Sykes ,Paul Diaz ,Matthew Scalo ,Tom Stevens ,Chris Jacobs ,Matt Scalo ,Bryan Riggsbee ,Nicole Lambert ,Goldman Sachs ,Nasdaq ,Genetics Inc ,Research Use ,Tech Solutions ,American College Of Medicine Genetics ,Health Photo ,National Cancer Institute On Unsplash ,Myriad Genetics ,Call Transcript February ,Myriad Genetics Fourth Quarter ,Earnings Conference ,Myriad Genetic Four Quarter ,Full Year ,Senior Vice President ,Chief Executive Officer ,Chief Financial Officer ,Chief Operating Officer ,Chief Commercial ,Myrisk Hereditary Cancer Testing ,Gateway Genomics ,Myriad Complete ,Chief Commercial Officer ,National Cancer Institute ,American College ,Medicine Genetics ,Unified Order Management System ,Research Use Only ,Myriad Genetics Continuum ,Rev Cycle ,Investor Relations ,Just Started Paying Dividends ,Motley Fool ,High Growth Stock ,Myriad Genetics Inc ,